Cost of age-related macular degeneration in Italy. The retrospective analysis of the study CARMA;Costi dell degenerazione maculare legata all'età in Italia

PharmacoEconomics - Italian Research Articles

Volumn 4, Issue 2, 2002, Pages 57-63

  Denti, C ^a   Garattini, Livio ^a   Lanzetta, P ^b   Parazzini, F ^a   Ricci, E ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Ospedale di Udine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; HEALTH CARE COST; HUMAN; ITALY; LASER SURGERY; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; RETINA MACULA AGE RELATED DEGENERATION; RETIREMENT; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0036400440     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03320595     Document Type: Article

References (16)

1. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham Eye Study I. Outline and major prevalence findings. Am J Epidemiol 1977; 106: 17-32
2. Ferris III FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy, Arch Ophthalmol 1984; 102: 1640-2
3. Hyman L. Epidemiology of AMD. In: Hampton GR, Nelson PT, eds. Age-related Macular degeneration: principles and practice. New York: Raven Press, 1992: 1-35
4. Pizzarello LD. The dimensions of the problem of eye disease among the elderly. Ophthalmology 1987; 94: 1191-5
5. Macular Photocoagulation Study Group. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 1997; 115: 741-7
6. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroideal neovascularization in age related macular degeneration with verteporfin. One-year results of two randomized clinical trials-TAP Report 1. Arch Ophthalmol 1999; 117: 1329-45
7. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Ophthalmol 1991; 111: 1200-9
8. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986; 104: 503-12
9. Davis C, Lovie-Kitchin J, Thompson B. Psychological adjustment to age-related macular degeneration. J Vis Impair Blind 1995; 1: 16-27;
10. Alexander MF, Maguire MG, Lletman TM, et al. Assessment of visual function in patients with age-related macular degeneration and low visual acuity. Arch Ophthalmol 1998; 105: 1543-7;
11. Williams RA, Brody BL, Thomas RG, et al. The psychological impact of macular degeneration. Arch Ophthalmol 1998; 116: 514-20
12. Brown GC, Sharma S, Brown MM, Kistler J. Utilities and age related macular degeneration. Arch Ophthalmol 2000; 118: 47-51
13. Ministero della Sanità. Decreto Ministeriale n. 150 del 22 luglio 1996. Prestazioni di assistenza specialistica ambulatoriale erogabili nell'ambito del Servizio Sanitario Nazionale e relative tariffe. Supplemento ordinario alla Gazzetta ufficiale n.216 del 14 settembre 1996. Serie Generale
14. Ministero della Sanità. Decreto Ministeriale n. 178 del 30 giugno 1997. Aggiornamento delle tariffe delle prestazioni di assistenza ospedaliera, di cui al Decreto Ministeriale 14 dicembre 1994. Supplemento ordinario alla Gazzetta ufficiale n. 209 del 8 Settembre 1197. Serie Generale
15. Sharma S. Update in retina: photodynamic therapy for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Can J Ophthalmol 2001; 36: 7-10
16. Brown GC, Brown MM, Sharma S, et al. Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology 2000; 107: 1374-80